PRESS RELEASES

Date Title View
Toggle Summary Chimerix Announces Third Quarter 2017 Financial Results
Conference Call at 8:30 a.m. ET Today DURHAM, N.C. , Nov. 08, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today reported financial results and provided a  corporate  update  for  the  third  quarter
View HTML
Toggle Summary Chimerix to Present at the Stifel 2017 Healthcare Conference
DURHAM, N.C. , Nov. 07, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey , M.D., M.P.H., Chief Executive Officer of Chimerix and Garrett Nichols , M.D., M.S., Chief
View HTML
Toggle Summary Chimerix to Announce Third Quarter 2017 Financial Results on November 8, 2017
DURHAM, N.C. , Nov. 01, 2017 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients, today announced that it will host a live conference call and audio webcast on
View HTML
Toggle Summary Chimerix to Present at Cantor Fitzgerald Global Healthcare Conference
DURHAM, N.C. , Sept. 20, 2017 (GLOBE NEWSWIRE) -- Chimerix  (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey , M.D., M.P.H., President and Chief Executive Officer of Chimerix, will present a corporate
View HTML
Toggle Summary Chimerix Appoints Heather Knight-Trent, PharmD, as Vice President of Regulatory Affairs
DURHAM, N.C. , Sept. 12, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company committed to discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients, today announced the appointment of Heather Knight-Trent , PharmD, as Vice
View HTML
Toggle Summary Chimerix Announces Second Quarter 2017 Financial Results
- Conference Call at 8:30 a.m. ET Today -
View HTML
Toggle Summary Chimerix to Announce Second Quarter 2017 Financial Results on August 7, 2017
DURHAM, N.C., July 31, 2017 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients, today announced that it will host a live conference call and audio webcast on
View HTML
Toggle Summary Chimerix Announces First Quarter 2017 Financial Results
- Conference Call at 8:30 a.m. ET Today -
View HTML
Toggle Summary Chimerix to Announce First Quarter 2017 Financial Results on May 9, 2017
DURHAM, N.C. , May 02, 2017 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients, today announced that it will host a live conference call and audio webcast on
View HTML
Toggle Summary Chimerix to Host Annual Investor Update on April 27, 2017
DURHAM, N.C. , April 20, 2017 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company committed to discovering, developing and commercializing medicines that address significant, unmet medical needs, today announced that it will host the Company's annual investor update event
View HTML